Datar Cancer Genetics Press Releases

• Published on May 31, 2024 - 13:30 GMT

  

  Datar Cancer Genetics Publishes Real-World Data Highlighting the Benefits of Multi-Omics Tumor Profiling at ASCO 2024

  GUILDFORD, SURREY, UNITED KINGDOM, May 31, 2024 /⁨EINPresswire.com⁩/ -- Datar Cancer Genetics (DCG) today announced the publication of data related to the clinical utility and benefits of multi-omics tumor profiling at the 2024 American Society of Clinical …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on May 28, 2024 - 02:05 GMT

  

  Datar Cancer Genetics To Share Key Scientific Findings at the 2024 American Society of Clinical Oncology Annual Meeting

  GUILDFORD, SURREY, UNITED KINGDOM, May 28, 2024 /⁨EINPresswire.com⁩/ -- Datar Cancer Genetics (DCG) today announced it will release ten scientific data sets across its diverse oncology portfolio at the 2024 American Society of Clinical Oncology (ASCO) …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on January 26, 2023 - 13:00 GMT

  

  Datar Cancer Genetics Partners with Goodbody Health to Offer Innovative Cancer Screening

  LONDON, UNITED KINGDOM , January 26, 2023 /⁨EINPresswire.com⁩/ -- Datar Cancer Genetics (Datar), a world-leading liquid biopsy company, today announced its partnership with Goodbody Health Limited (Goodbody Health) to offer its innovative Circulating Tumor …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on December 13, 2022 - 09:06 GMT

  

  Prof. Sendurai Mani joins the Datar Cancer Genetics Scientific Advisory Board

  RALEIGH, NORTH CAROLINA, UNITED STATES, December 13, 2022 /⁨EINPresswire.com⁩/ -- Datar Cancer Genetics, a world leader in non-invasive cancer screening and diagnostics, today announced that Dr. Sendurai Mani, Ph.D has joined their Scientific Advisory …

  Distribution channels: Business & Economy, Companies ...
• Published on December 9, 2022 - 07:36 GMT

  

  Datar Cancer Genetics nominates Dr. Razelle Kurzrock to the Board of Scientific Advisors

  RALEIGH, NORTH CAROLINA, UNITED STATES, December 9, 2022 /⁨EINPresswire.com⁩/ -- Datar Cancer Genetics, a world leader in non-invasive cancer screening, diagnostics, and precision oncology, today announced that it has appointed Dr. Razelle Kurzrock, a …

  Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
• Published on December 6, 2022 - 10:08 GMT

  

  Datar Cancer Genetics Designates Dr. Massimo Cristofanilli as Chairman of the Board of Scientific Advisors

  RALEIGH, NORTH CAROLINA, UNITED STATES, December 6, 2022 /⁨EINPresswire.com⁩/ -- Datar Cancer Genetics, a world leader in non-invasive cancer screening and diagnostics, today announced that it had designated Dr. Massimo Cristofanilli, a world-renowned …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
• Published on October 17, 2022 - 02:30 GMT

  

  Datar Cancer Genetics Partners With AVMLabs To Offer Trucheck Cancer Screening Solution Across Bahrain

  LONDON, UNITED KINGDOM, October 17, 2022 /⁨EINPresswire.com⁩/ -- Datar Cancer Genetics has announced its collaboration with AVM Labs to offer its innovative, blood-based Trucheck cancer screening solutions across Bahrain. Datar Cancer Genetics has been at …

  Distribution channels: Business & Economy, Companies ...
• Published on July 13, 2022 - 11:51 GMT

  

  Landmark Liquid Biopsy Study Shows Accurate Detection of Early-Stage Breast Cancer

  Study establishes the high clinical performance of ‘TrucheckTM - Breast’ blood test. LONDON, UNITED KINGDOM, ENGLAND, July 13, 2022 /⁨EINPresswire.com⁩/ -- Datar Cancer Genetics (Datar) a world-leading liquid biopsy company today announced the publication …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on June 13, 2022 - 07:00 GMT

  

  DATAR CANCER GENETICS PARTNERS WITH THE CANCER SCREENING TRUST TO OFFER BLOOD-BASED TEST FOR EARLY CANCER DETECTION

  LONDON, UNITED KINGDOM, June 13, 2022 /⁨EINPresswire.com⁩/ -- Datar Cancer Genetics has announced its partnership with U.K. based The Cancer Screening Trust to offer its innovative, blood-based, cancer screening Trucheck solution. Datar Cancer Genetics has …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on April 12, 2022 - 13:30 GMT

  

  DATAR CANCER GENETICS PARTNERS WITH ARTEMIS DNA TO OFFER BLOOD-BASED TEST FOR EARLY CANCER DETECTION IN VIETNAM

  MUMBAI, INDIA, April 12, 2022 /⁨EINPresswire.com⁩/ -- Mumbai / Washington: Datar Cancer Genetics, a world leader in non-invasive cancer screening and diagnostics, today announced that it has entered into an agreement with Artemis DNA Vietnam, to offer its …

  Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
• Published on April 11, 2022 - 09:00 GMT

  DATAR CANCER GENETICS ENTERS INTO PARTNERSHIP WITH THE LONDON CLINIC TO OFFER ENHANCED CANCER TESTING SERVICES

  LONDON, UNITED KINGDOM, April 11, 2022 /⁨EINPresswire.com⁩/ -- Datar Cancer Genetics has announced its partnership with The London Clinic, the UK’s leading independent charitable hospital, to provide precision oncology-based solutions to improve the …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...